2024 Annual Report to Shareholders
Enjoyed this read?
Stay up to date with our latest research.
BACK TO NEWS
Related articles
Corporate Presentations
Webcast Video Recording: Actinogen updated Depression Trial results and implications presentation
Actinogen • August 30, 2024
Press Releases and Media
Actinogen announces further positive results on depression in the XanCIDD phase 2a trial
PR Newswire • August 26, 2024
Corporate Presentations
Webcast Video Recording: Actinogen XanaCIDD topline results presentation
Actinogen • August 12, 2024